MedTrace Logo

China PEACE-Prospective AMI Study

NCT01624909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4286

Last updated 2015-08-31

No results posted yet for this study

Summary

Coronary heart disease (CHD) and heart attacks pose a serious health risk to men and women, however little information is available about how evidence-based therapies are incorporated appropriately into routine clinical practice in China. In addition, basic data and evidence about safety and efficacy of treatment for AMI is limited. By consecutively recruiting AMI patients in 40 hospitals of different levels, this study will examine various real-life factors, that may affect patients recovery after a heart attack. Practical guidelines and risk model for AMI patients will be established based on the findings, to improve patients outcomes in future finally.

Conditions

Sponsors & Collaborators

  • Ministry of Health, China

    collaborator OTHER_GOV

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Lixin Jiang, M.D., Ph.D. · China National Center for Cardiovascular Diseases

  • Harlan M Krumholz, M.D., S.M. · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-05-31
Completion
2015-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01624909 on ClinicalTrials.gov